Similar Papers

Paper Title
Journal
Date
Author
Difference of protein 53 expression based on radiation therapy response in cervical cancer
H P Pasaribu ... R Rivany
IOP Conference Series: Earth and Environmental Science | VOL. 125
H P Pasaribu, et. al.H P Pasaribu ... R Rivany
01 Mar 2018
Original Articles: Bladder Cancer: Neoadjuvant Cisplatin Chemotherapy Before Radical Cystectomy in Invasive Transitional Cell Carcinoma of the Bladder: A Prospective Randomized Phase III Study
Jose A Martinez-Pineiro ... Santiago Isorna
Journal of Urology | VOL. 153
Jose A Martinez-Pineiro, et. al.Jose A Martinez-Pineiro ... Santiago Isorna
01 Mar 1995
Aldehyde dehydrogenase 1 (ALDH1) expression is associated with a poor prognosis of bladder cancer
Ning Xu ... Ai-Ping Shi
Cancer Epidemiology | VOL. 39
Ning Xu, et. al.Ning Xu ... Ai-Ping Shi
03 Apr 2015
Genomic Landscape of Experimental Bladder Cancer in Rodents and Its Application to Human Bladder Cancer: Gene Amplification and Potential Overexpression of Cyp2a5/CYP2A6 Are Associated with the Invasive Phenotype.
Kazuhiro Kanemoto ... Francisco X Real
PloS one | VOL. 11
Kazuhiro Kanemoto, et. al.Kazuhiro Kanemoto ... Francisco X Real
30 Nov 2016
View more papers

More From: International Journal of Radiation Oncology*Biology*Physics

Paper Title
Journal
Date
Author
Defining the optimal radiation-induced lymphopenia metric to discern its survival impact in esophageal cancer.
Pim J.J Damen ... Peter S.N Van Rossum
International Journal of Radiation Oncology*Biology*Physics | VOL. -
Pim J.J Damen, et. al.Pim J.J Damen ... Peter S.N Van Rossum
01 Jan 2025
Issue Highlights
-
International Journal of Radiation Oncology*Biology*Physics | VOL. -
--
01 Jan 2025
Combined molecular subclass and immune phenotype correlate to atezolizumab plus radiation therapy response in invasive bladder cancer: BPT-ART Phase II study
Yoshiyuki Nagumo ... Hiroyuki Nishiyama
International Journal of Radiation Oncology*Biology*Physics | VOL. -
Yoshiyuki Nagumo, et. al.Yoshiyuki Nagumo ... Hiroyuki Nishiyama
01 Jan 2025
Pelvic regional control with 25Gy in 5 fractions in SBRT for high risk prostate cancer: Pooled prospective outcomes from the SHARP consortium
Vedang Murthy ... Amar U Kishan
International Journal of Radiation Oncology*Biology*Physics | VOL. -
Vedang Murthy, et. al.Vedang Murthy ... Amar U Kishan
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.